Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the phase 1 portion of the study is to determine the safe dose of S-1 and
cisplatin that can be administered in gastric cancer patients.
The purpose of the phase 2 portion of the study is to determine the antitumor activity of the
S-1 and cisplatin regimen established from phase 1 in patients with advanced gastric cancer.